Skip to main content

Grey Cloak Tech Completes Successful Pilot Study on its Fuel4Thought™ Migraine Formula with Positive Results

Written by Customer Service on . Posted in Public Companies.

Fuel4Thought™ proprietary Migraine formulation is similar to their recently released Brain Booster, but scientifically designed to try and provide millions of sufferers a natural solution.
LAS VEGAS, Dec. 22, 2020 (GLOBE NEWSWIRE) — Grey Cloak Tech Inc. (OTCQB: GRCK) – (soon to be Healthy Extracts Inc. pending a corporate name change), a company engaged in proprietary development of natural plant-based formulations as well as sales and distribution of cardiovascular and neuro products, is pleased to announce its subsidiary, Ultimate Brain Nutrients™, (UBN) has announced a successful completion of a pilot study for its proprietary Fuel4Thought™ (F4T™) formulation to help with Migraines.Dr. Gerald Haase, MD. a key consultant to the Medical Advisory Board said, “We were excited to study this unique F4T™ formulation, as previous scientific data had indicated that this combination of natural ingredients could have a positive benefit for Migraines. These initial results were dramatic and the scientific paper has been submitted for publication.”“Nearly 40 million people suffer from some form of Migraines in just the United States,” stated Duke Pitts, President. “This version of our F4T™ formulation could provide a natural alternative for Migraines and will join our current release of Brain Booster in the middle of 2021. They will be a huge part of attaining our sales goals for the year.”UBN has two patents issued and three pending on its proprietary formulations. UBN’s products have been 20 years in development with 90 iterations and is supported by 85 clinical studies of its three-main Ingredients. In addition, UBN has filed for an application to the US Food and Drug Administration to make Qualified Health Claims for its migraine formulation.About Grey Cloak Tech Inc.
Grey Cloak Tech Inc. (OTCQB: GRCK) name change pending to Healthy Extracts Inc.), through its two subsidiaries, BergaMet NA and Ultimate Brain Nutrients (“UBN”), is engaged in proprietary research and development of natural plant-based formulations, as well as sales and distribution of natural ingredient cardiovascular and neuro products. For more information, visit the company’s websites:
www.healthyextractsinc.com, www.bergametna.com, www.ubnutrients.comAbout Ultimate Brain Nutrients
Grey Cloak’s Ultimate Brain Nutrients (“UBN”) subsidiary is a science-based company that develops unique, plant-based superior health technology neuro-products that improve brain health, including memory, cognition, focus and neuro-energy. UBN’s KETONOMICS® proprietary formulations – targeting brain activity, focus, headache and cognitive behavior — provide multiple intellectual property license opportunities for monetizing the company’s portfolio. License opportunities include multiple beverage formats, individual products, proprietary mixtures and other food platforms. UBN has five unique formulation patents – two issued and three pending – targeting brain activity, memory, focus, headache and cognitive behavior. Learn more at www.ubnutrients.com.About BergaMet NA
BergaMet NA, a wholly owned subsidiary of Grey Cloak Technologies (OTCQB: GRCK), is a provider of nutraceutical natural heart health supplements. Based in Nevada, BergaMet researches and develops proprietary, natural, plant-based formulations. BergaMet also provides sales and distribution of natural neuro products that feature superior health technologies based on clinical and doctor supported evidence for maintaining a healthy immune system and improving metabolic syndrome. Learn more at www.bergametna.com.Forward-Looking Statements and Safe Harbor Notice
All statements other than statements of historical facts included in this press release are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as “projected,” “expect,” “possibility” and “anticipate.” The achievement or success of the matters covered by such forward-looking statements involves significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company’s Annual Report on Form 10-K filed with the SEC on April 1, 2020, and future periodic reports filed with the SEC. All of the Company’s forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.
The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release.Grey Cloak Tech Inc.:
Info@GreyCloakTech.com Corporate Communications:
Grey Cloak Tech Inc.:
www.healthyextractsinc.com 
info@healthyextractsinc.com 

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.